The authors propose an MS care model that combines remote tracking with clinic visits, but they did not test it.
The authors describe a plan for combining care at home with visits to a clinic. Wearable devices and remote check-ins would collect information between visits. That information could help care teams decide when someone needs an exam, brain scan, or other test. The plan also calls for different types of care staff to share information. The authors discuss artificial intelligence (computer tools that look for patterns in data) as a possible future addition.
This article is about a proposed care model for people with MS, not a study of patients. It addresses the gaps that can occur between clinic visits. The proposed model would use remote information to guide decisions about in-person care. It also aims to give people with MS a more active role in their care. The article may interest caregivers and care teams, but it reports no results from using the model.
You should know that the authors did not test this care model with patients. They report no sample size or measured health outcomes. The article does not show whether this approach improves MS care.
AI-generated summary — for informational purposes only, not medical advice
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More11/1/2026
In a study of 294 pregnancies, MS flare-ups were uncommon after pausing two treatments. Learn what t
Read More10/16/2026
Two rare conditions can look like MS. An Italian study links certain treatments to more time without
Read More10/16/2026
A review found lower inflammation in MS animal models, but no proof these drugs help people with MS.
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like NPJ digital medicine often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.